Literature DB >> 7805906

Alleviation of acrosome reaction prematurity by sperm treatment with egg yolk.

J Tesarik1, C Mendoza.   

Abstract

OBJECTIVE: To examine the effects of egg yolk on the spontaneous and ionophore-induced acrosome reaction (AR) and sperm-zona pellucida (ZP) binding in spermatozoa from patients with AR prematurity.
DESIGN: Prospective analysis.
SETTING: Private hospital, public research center, and a university-based laboratory. PATIENTS: In vitro fertilization patients selected on the basis of previous AR testing.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Frequency of the AR, number of ZP-bound spermatozoa.
RESULTS: The pretreatment of spermatozoa with egg yolk decreased the frequency of AR occurring spontaneously during subsequent sperm incubation in capacitating medium but did not modify the sperm response to ionophore. The egg yolk-treated spermatozoa also showed a greater capacity of binding the ZP than their untreated counterparts.
CONCLUSIONS: The pretreatment of spermatozoa with egg yolk alleviates the sperm-ZP binding deficiency resulting from premature initiation of the AR and may be helpful in IVF with patients showing this anomaly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805906     DOI: 10.1016/s0015-0282(16)57311-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  GIV/Girdin, a non-receptor modulator for Gαi/s, regulates spatiotemporal signaling during sperm capacitation and is required for male fertility.

Authors:  Sequoyah Reynoso; Vanessa Castillo; Gajanan Dattatray Katkar; Inmaculada Lopez-Sanchez; Sahar Taheri; Celia Espinoza; Cristina Rohena; Debashis Sahoo; Pascal Gagneux; Pradipta Ghosh
Journal:  Elife       Date:  2021-08-19       Impact factor: 8.140

2.  Src family kinases-mediated negative regulation of sperm acrosome reaction in chickens (Gallus gallus domesticus).

Authors:  Chathura Priyadarshana; Rangga Setiawan; Atsushi Tajima; Atsushi Asano
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.